These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7390422)

  • 1. Reducing psychotropic drug use in an institution for the retarded.
    LaMendola W; Zabaria ES; Carver M
    Hosp Community Psychiatry; 1980 Apr; 31(4):271-2. PubMed ID: 7390422
    [No Abstract]   [Full Text] [Related]  

  • 2. Frequency of and determinants for psychotropic drug use in an institution for the mentally retarded.
    Linaker OM
    Br J Psychiatry; 1990 Apr; 156():525-30. PubMed ID: 1974820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An assessment program to reduce drug use with the mentally retarded.
    Fielding LT; Murphy RJ; Reagan MW; Peterson TL
    Hosp Community Psychiatry; 1980 Nov; 31(11):771-3. PubMed ID: 7429449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developmentally disabled, doubly disadvantaged.
    Parker G
    Med J Aust; 1991 Jul; 155(2):68-71. PubMed ID: 1857308
    [No Abstract]   [Full Text] [Related]  

  • 5. Psychotropic drug use with successful and unsuccessful community placed developmentally disabled groups.
    Harder SR; Kalachnik JE; Jensen MA; Feltz J
    Res Dev Disabil; 1987; 8(2):191-202. PubMed ID: 2890188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Considerations in the use of psychotropic drugs in elderly mentally retarded persons.
    Aman MG
    J Ment Defic Res; 1990 Feb; 34 ( Pt 1)():1-10. PubMed ID: 2182880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of the prescribing for people with learning disabilities living in the community and in National Health Service care.
    Branford D
    J Intellect Disabil Res; 1994 Dec; 38 ( Pt 6)():577-86. PubMed ID: 7881229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unnecessary psychotropic drug prescription in primary care for people with intellectual disability.
    Trollor J; Salomon C
    Evid Based Ment Health; 2016 May; 19(2):62. PubMed ID: 27075445
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacologic interventions in agitated mentally retarded patients].
    Sidoun P; Hillel J; Grunberg F; Elie R
    Can J Psychiatry; 1989 Feb; 34(1):63-8. PubMed ID: 2647272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pursuit of the magic pill: the overuse of psychotropic medications in children with intellectual and developmental disabilities in the USA.
    McLaren JL; Lichtenstein JD
    Epidemiol Psychiatr Sci; 2019 Aug; 28(4):365-368. PubMed ID: 30353794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of pharmacotherapy: current status and future directions.
    Aman MG
    J Ment Defic Res; 1987 Jun; 31 ( Pt 2)():121-30. PubMed ID: 2887660
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of psychotropic medication in people with a learning disability.
    Jenkins R
    Br J Nurs; 2000 Jul 13-26; 9(13):844-50. PubMed ID: 11261057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study.
    Sheehan R; Hassiotis A; Walters K; Osborn D; Strydom A; Horsfall L
    BMJ; 2015 Sep; 351():h4326. PubMed ID: 26330451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, patterns and factors associated with psychotropic use in older adults with intellectual disabilities in Ireland.
    O'Dwyer M; Peklar J; Mulryan N; McCallion P; McCarron M; Henman MC
    J Intellect Disabil Res; 2017 Oct; 61(10):969-983. PubMed ID: 28639298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychotropic medication use in adolescents with intellectual disability living in the community.
    Doan T; Ware R; McPherson L; van Dooren K; Bain C; Carrington S; Einfeld S; Tonge B; Lennox N
    Pharmacoepidemiol Drug Saf; 2014 Jan; 23(1):69-76. PubMed ID: 23929635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Psychotropic Prescribing Practices for Children and Adolescents with Intellectual Disabilities: A Cohort Study Using a Large-scale Health Insurance Database].
    Inoue Y; Okumura Y; Fujita J
    Seishin Shinkeigaku Zasshi; 2016; 118(11):823-833. PubMed ID: 30620838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A critical appraisal of recent drug research in mental retardation: the Coldwater studies.
    Aman MG; Singh NN
    J Ment Defic Res; 1986 Sep; 30 ( Pt 3)():203-16. PubMed ID: 2878082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychopathology in institutionalised mentally retarded adults.
    Linaker OM; Nitter R
    Br J Psychiatry; 1990 Apr; 156():522-5. PubMed ID: 2386861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comments on the community drug treatment prevalence survey by Davis et al. (1981).
    Gadow KD
    J Ment Defic Res; 1987 Jun; 31 ( Pt 2)():215-9. PubMed ID: 3625768
    [No Abstract]   [Full Text] [Related]  

  • 20. An Exploratory Study among Intellectual Disability Physicians on the Care and Coercion Act and the Use of Psychotropic Drugs for Challenging Behaviour.
    Bij de Weg JC; Honingh AK; Teeuw M; Sterkenburg PS
    Int J Environ Res Public Health; 2021 Sep; 18(19):. PubMed ID: 34639540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.